Fructooligosaccharide decreases the production of uremic toxin precursor through modulating gut microbes mediated tyrosine metabolism pathway

[1]  A. Kraneveld,et al.  Supplementation of dietary non-digestible oligosaccharides from birth onwards improve social and reduce anxiety-like behaviour in male BALB/c mice , 2020, Nutritional neuroscience.

[2]  J. Duan,et al.  Improved dialysis removal of protein-bound uremic toxins by salvianolic acids. , 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[3]  J. Recio-Rodríguez,et al.  Postprandial effects of breakfast glycaemic index on cognitive performance among young, healthy adults: A crossover clinical trial , 2020, Nutritional neuroscience.

[4]  G. Qin,et al.  Fructo-Oligosaccharide Alleviates Soybean-Induced Anaphylaxis in Piglets by Modulating Gut Microbes , 2018, Front. Microbiol..

[5]  G. Nolan,et al.  A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites , 2017, Nature.

[6]  A. Pandey,et al.  Prebiotic Oligosaccharides: Special Focus on Fructooligosaccharides, Its Biosynthesis and Bioactivity , 2017, Applied Biochemistry and Biotechnology.

[7]  Maxim N. Artyomov,et al.  The microbial metabolite desaminotyrosine protects from influenza through type I interferon , 2017, Science.

[8]  M. Vaneechoutte,et al.  p-Cresyl Sulfate , 2017, Toxins.

[9]  G. Beck,et al.  The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials , 2016, BMC Nephrology.

[10]  S. Uchida,et al.  Prediction of drug interaction between oral adsorbent AST-120 and concomitant drugs based on the in vitro dissolution and in vivo absorption behavior of the drugs , 2016, European Journal of Clinical Pharmacology.

[11]  R. Vanholder,et al.  Future Avenues to Decrease Uremic Toxin Concentration. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  S. Eiam‐Ong,et al.  Effects of Fructo-Oligosaccharide Supplementation on Constipation in Elderly Continuous Ambulatory Peritoneal Dialysis Patients , 2016, Peritoneal Dialysis International.

[13]  Xusheng Liu,et al.  Rhubarb Enema Attenuates Renal Tubulointerstitial Fibrosis in 5/6 Nephrectomized Rats by Alleviating Indoxyl Sulfate Overload , 2015, PloS one.

[14]  Annaïg Lan,et al.  The deleterious metabolic and genotoxic effects of the bacterial metabolite p-cresol on colonic epithelial cells. , 2015, Free radical biology & medicine.

[15]  Jennifer M. Brulc,et al.  Carbohydrate catabolic diversity of bifidobacteria and lactobacilli of human origin. , 2015, International journal of food microbiology.

[16]  M. A. Ganaie,et al.  Recycling of cell culture and efficient release of intracellular fructosyltransferase by ultrasonication for the production of fructooligosaccharides. , 2014, Carbohydrate polymers.

[17]  Shweta Kumari,et al.  Biotechnological approaches for the production of prebiotics and their potential applications , 2013, Critical reviews in biotechnology.

[18]  Mai-Szu Wu,et al.  Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients--a prospective cohort study. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  R. Rastall.  Functional oligosaccharides: application and manufacture. , 2010, Annual review of food science and technology.

[20]  K. Verbeke,et al.  p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  K. Verbeke,et al.  p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[22]  P. Rutgeerts,et al.  Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[23]  J. Huneau,et al.  Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences , 2007, Amino Acids.

[24]  R. Vanholder,et al.  P-cresol, a uremic retention solute, alters the endothelial barrier function in vitro , 2004, Thrombosis and Haemostasis.

[25]  Raymond Vanholder,et al.  Review on uremic toxins: classification, concentration, and interindividual variability. , 2003, Kidney international.

[26]  M. Roberfroid,et al.  Inulin and Oligofructose as Dietary Fiber: A Review of the Evidence , 2001, Critical reviews in food science and nutrition.

[27]  F. Schneider,et al.  Fermentations of fructo‐oligosaccharides and their components by Bifidobacterium infantis ATCC 15697 on batch culture in semi‐synthetic medium , 2001, Journal of applied microbiology.

[28]  G R Gibson,et al.  Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human use. , 2000, The Journal of nutrition.